Page last updated: 2024-08-26

nsc-87877 and Neoplasms

nsc-87877 has been researched along with Neoplasms in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (33.33)24.3611
2020's2 (66.67)2.80

Authors

AuthorsStudies
Bu, H; Yang, CY; Yuan, X; Zhang, H; Zhou, J1
Song, Y; Wang, S; Yang, X; Yu, B; Zhao, M1
Bae, EA; Kang, CY; Kim, EK; Kim, TG; Lee, KA; Lee, YS; Song, YC1

Reviews

2 review(s) available for nsc-87877 and Neoplasms

ArticleYear
Recent Advances of SHP2 Inhibitors in Cancer Therapy: Current Development and Clinical Application.
    Journal of medicinal chemistry, 2020, 10-22, Volume: 63, Issue:20

    Topics: Antineoplastic Agents; Clinical Trials as Topic; Crystallography, X-Ray; Drug Development; Enzyme Inhibitors; Human-Animal Bond; Humans; Models, Molecular; Molecular Structure; Mutation; Neoplasms; Protein Tyrosine Phosphatase, Non-Receptor Type 11; Signal Transduction

2020
Strategies Targeting Protein Tyrosine Phosphatase SHP2 for Cancer Therapy.
    Journal of medicinal chemistry, 2022, 02-24, Volume: 65, Issue:4

    Topics: Animals; Antineoplastic Agents; Drug Design; Drug Discovery; Enzyme Inhibitors; Humans; Neoplasms; Protein Tyrosine Phosphatase, Non-Receptor Type 11

2022

Other Studies

1 other study(ies) available for nsc-87877 and Neoplasms

ArticleYear
A multimeric carcinoembryonic antigen signal inhibits the activation of human T cells by a SHP-independent mechanism: a potential mechanism for tumor-mediated suppression of T-cell immunity.
    International journal of cancer, 2015, Jun-01, Volume: 136, Issue:11

    Topics: Carcinoembryonic Antigen; Cell Adhesion; Cell Line; Cell Proliferation; Gene Expression Regulation; HeLa Cells; Humans; Immune Tolerance; Lymphocyte Activation; Neoplasms; Protein Tyrosine Phosphatase, Non-Receptor Type 11; Quinolines; Receptors, Antigen, T-Cell; Signal Transduction; T-Lymphocytes

2015